New gene therapy shows promise in reversing heart failure in pigs, with human trials planned.

A new gene therapy has shown promising results in reversing heart failure in pigs by delivering a critical heart protein, cBIN1, using a harmless virus. This therapy significantly improved heart function and efficiency, and researchers plan to adapt it for human trials, aiming for FDA approval by fall 2025. The treatment could offer a transformative option for heart failure patients if successful in human testing.

3 months ago
16 Articles

Further Reading